よむ、つかう、まなぶ。
資料２－２ WHO 推奨リスト (5 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/newpage_00058.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 研究開発及び生産・流通部会 季節性インフルエンザワクチンの製造株について検討する小委員会（第8回 4／24）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
World Health
rdaniZation
〇
Influenza B Yamagata lineage egg-derived~ candidate vaccine Viruses
for development and production of vaccines for use in the 2023-2024
northern hemisphere influenza season
上ntigemic and genietic analyses are herTarrmed by the WHO Collabarating Centres nf the Global Influenza Surveillance and
Response System (GISRSj. Unless ntherwise specified, all cardidate waccine wiruses posted nn this tahle hawe passed two-
way haemag如utinatian inhibition [HI| test. Matinnal nr Regional Control autharities approve the comnosition and
farmulatian gf waccines used in Each cpuntry=
25 February 2023
Candidate vaccine viruses (antigenically like B/Phuket/3073/2013 (egg
derived) - Accession number (GISAID): EPI_ ISL 168822
」 Candidate Typegfvirus or | Developing 。
Parent virus Vaccine virus ョューーー netituta Available from
WHO CCs
Wildt |
B/Phuket/3073/2013 MHRA, UK
BVR-1B Classical SeqIru5 VIDRLL 貞ustralia
Wild type virus CDC, USAA
- MHRAL UK
B/California/12/2015 PA-53A Cassical NYME NYMC, USA
- MHRALUK
BK-59B Classical NYIMC NYMC_ USA
- - WHO CCs
B/Brisbans/9/2014 Wild type virus MHRA_ UK
- CDC. US
B/Utah/09/2014 Wild type virus MHRA_ UK
MHRAL UK
B加-63 Classical NYIMC NYM 吉 USA
B/Arizona/10/2015 MHRA_ UK
B光-三3上 Classical MYIMC
asSiCd NYMC USA
B/Hong Wild type virus THRA ーー
R 3417/は014 BB区-5了 Classical MYIMC
Ongア / 55IC NYMC_ USA
引用元 : WHOウェブサイト
https://www.who.int/teams/global-influenza-programme/vaccines/who-
recommendations/candidate-vaccine-viruseSs
rdaniZation
〇
Influenza B Yamagata lineage egg-derived~ candidate vaccine Viruses
for development and production of vaccines for use in the 2023-2024
northern hemisphere influenza season
上ntigemic and genietic analyses are herTarrmed by the WHO Collabarating Centres nf the Global Influenza Surveillance and
Response System (GISRSj. Unless ntherwise specified, all cardidate waccine wiruses posted nn this tahle hawe passed two-
way haemag如utinatian inhibition [HI| test. Matinnal nr Regional Control autharities approve the comnosition and
farmulatian gf waccines used in Each cpuntry=
25 February 2023
Candidate vaccine viruses (antigenically like B/Phuket/3073/2013 (egg
derived) - Accession number (GISAID): EPI_ ISL 168822
」 Candidate Typegfvirus or | Developing 。
Parent virus Vaccine virus ョューーー netituta Available from
WHO CCs
Wildt |
B/Phuket/3073/2013 MHRA, UK
BVR-1B Classical SeqIru5 VIDRLL 貞ustralia
Wild type virus CDC, USAA
- MHRAL UK
B/California/12/2015 PA-53A Cassical NYME NYMC, USA
- MHRALUK
BK-59B Classical NYIMC NYMC_ USA
- - WHO CCs
B/Brisbans/9/2014 Wild type virus MHRA_ UK
- CDC. US
B/Utah/09/2014 Wild type virus MHRA_ UK
MHRAL UK
B加-63 Classical NYIMC NYM 吉 USA
B/Arizona/10/2015 MHRA_ UK
B光-三3上 Classical MYIMC
asSiCd NYMC USA
B/Hong Wild type virus THRA ーー
R 3417/は014 BB区-5了 Classical MYIMC
Ongア / 55IC NYMC_ USA
引用元 : WHOウェブサイト
https://www.who.int/teams/global-influenza-programme/vaccines/who-
recommendations/candidate-vaccine-viruseSs